Daniele Bonvicini

Daniele Bonvicini

Auto-generated profile, based on publicly available information

Daniele Bonvicini

Department of Urgency and Emergency, Anesthesiology and Intensive Care Unit, University Hospital of Padova, Padova, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Minerva Anestesiologica
Verified
Journal Article
Closed access
ACAlessandro De Cassai
Alessandro De Cassai
DBDaniele Bonvicini
Daniele Bonvicini
CCChristelle Correale
Christelle Correale
LSLudovica Sandei
Ludovica Sandei
Serkan TulgarSerkan Tulgar
Serkan Tulgar
TTTommaso Tonetti
Tommaso Tonetti
The erector spinae plane (ESP) block is an interfascial block proposed to provide analgesia for chronic thoracic pain. It consists in an injection of local anesthetic in a plane between the transverse process and the erector spinae muscles group. We performed a systematic review of literature following the PRISMA Statement Guidelines. The bibliographic search was conducted on September 2018. We included articles indexed in MEDLINE, EMBASE, Cochrane Library and Google Scholar. Search terms included the following: "erector spinae plane block" OR "ESP block" OR "erector spinae block." We identified 367 studies and after removal of 206 duplicates and exclusion of 18 records we manually searched 140 studies. We identified four randomized controlled trials, but the endpoints were heterogeneous preventing a statistical analysis; we performed then a qualitative review of the literature. Studies showed lower use of opioids and a longer time to first analgesic requirement in the ESP group. In one study, ESP block was found to be as effective as epidural analgesia. ESP block has a wide range of clinical indications. Its mechanism of action is still not thoroughly understood. Only two reports presented complications caused by the block. Although data suggests that ESP block is an easy and safe technique, more studies are needed to assess safety, complications rates and efficacy of this technique. In particular, we need well designed RCTs comparing ESP block to gold standard regional anesthesia technique. Nevertheless, ESP block is already a viable option for anesthesiologists all over the world.

1 February 2018 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
DBDaniele Bonvicini
Daniele Bonvicini
LTLorenzo Tagliapietra
Lorenzo Tagliapietra
AGAngelo Giacomazzi
Angelo Giacomazzi
EPErnesto Pizzirani
Ernesto Pizzirani

1 May 2020 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
ACAlessandro De Cassai
Alessandro De Cassai
GAGiulio Andreatta
Giulio Andreatta
DBDaniele Bonvicini
Daniele Bonvicini
ABAnnalisa Boscolo
Annalisa Boscolo
MMMarina Munari
Marina Munari
PNPaolo Navalesi
Paolo Navalesi

1 October 2017 in Minerva Anestesiologica
Verified
Journal Article
Closed access
DBDaniele Bonvicini
Daniele Bonvicini
AGAngelo Giacomazzi
Angelo Giacomazzi
EPErnesto Pizzirani
Ernesto Pizzirani
Article: Use of the ultrasound-guided erector spinae plane block in breast surgery - Minerva Anestesiologica 2017 October;83(10):1111-2 - Minerva Medica - Journals

1 July 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ASAnella Saviano
Anella Saviano
GCGian Marco Casillo
Gian Marco Casillo
FRFederica Raucci
Federica Raucci
APAlessia Pernice
Alessia Pernice
CSCristina Santarcangelo
Cristina Santarcangelo
Francesco MaioneFrancesco Maione
Francesco Maione
Alzheimer's disease (AD) is the most common type of dementia worldwide, characterized by the deposition of neurofibrillary tangles and amyloid-β (Aβ) peptides in the brain. Additionally, increasing evidence demonstrates that a neuroinflammatory state and oxidative stress, iron-dependent, play a crucial role in the onset and disease progression. Besides conventional therapies, the use of natural-based products represents a future medical option for AD treatment and/or prevention. We, therefore, evaluated the effects of a ribonucleotides-based ingredient (Ribodiet®) in a non-genetic mouse model of AD. To this aim, mice were injected intracerebroventricularly (i.c.v.) with Aβ1-42 peptide (3 µg/3 μl) and after with Ribodiet® (0.1-10 mg/mouse) orally (p.o.) 3 times weekly for 21 days following the induction of experimental AD. The mnemonic and cognitive decline was then evaluated, and, successively, we have assessed ex vivo the modulation of different cyto-chemokines on mice brain homogenates. Finally, the level of GFAP, S100β, and iron-related metabolic proteins were monitored as markers of reactive gliosis, neuro-inflammation, and oxidative stress. Results indicate that Ribodiet® lessens oxidative stress, brain inflammation, and amyloid pathology via modulation of iron-related metabolic proteins paving the way for its rationale use for the treatment of AD and other age-related diseases.

1 June 2018 in Minerva Anestesiologica
Verified
Journal Article
Closed access
AOArmando Olivieri
Armando Olivieri
DMDaniele Del Monte
Daniele Del Monte
LBLuca Benacchio
Luca Benacchio
DBDaniele Bonvicini
Daniele Bonvicini
MBMarco Baiocchi
Marco Baiocchi
EPErnesto Pizzirani
Ernesto Pizzirani
Article: An Observational Veneto Research on Ventilator-Associated Pneumonia (OVeRVAP): attributable mortality and cumulative incidence of ventilator-associated pneumonia - Minerva Anestesiologica 2018 July;84(7):811-9 - Minerva Medica - Journals